A serious complication of high-power short-duration radiofrequency atrial fibrillation ablation associated with genetic hypodysfibrinogenemia.

Kalaba, Frank; Qarmout, Mohammed; Lakshaman, Harini; Ahmed, Ammar; Manam, Rajendra; Shah, Dipak P

Kalaba, Frank; Qarmout, Mohammed; Lakshaman, Harini; Ahmed, Ammar; Manam, Rajendra; Shah, Dipak P.

Afiliación

Kalaba F; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Qarmout M; Internal Medicine Residency Program, Providence Hospital/Michigan State University College of Human Medicine, Southfield, Michigan.
Lakshaman H; Division of Cardiovascular Diseases, Providence Hospital/Michigan State University College of Human Medicine, Southfield, Michigan.
Ahmed A; Division of Cardiovascular Diseases, Providence Hospital/Michigan State University College of Human Medicine, Southfield, Michigan.
Manam R; Division of Hematology and Oncology, Providence Hospital/Michigan State University College of Human Medicine, Southfield, Michigan.
Shah DP; Division of Cardiovascular Diseases, Providence Hospital/Michigan State University College of Human Medicine, Southfield, Michigan.

HeartRhythm Case Rep ; 9(11): 800-801, 2023 Nov.

Article en En | MEDLINE | ID: mdl-38023675

Palabras clave

Atrial fibrillation; Hypodysfibrinogenemia; Kagoshima mutation; Radiofrequency ablation; Tamponade

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: HeartRhythm Case Rep Año: 2023 Tipo del documento: Article